Department of Public Health, Post-graduate School of Occupational Medicine, Catholic University of the Sacred Heart, Rome, Italy.
Independent Researcher, Kagawa-Ken, Japan.
Indian J Med Res. 2022 Jan;155(1):91-104. doi: 10.4103/ijmr.IJMR_474_21.
There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use Authorization by the WHO that can offer some protection to the world's population during the COVID-19 pandemic. Though research is being published all over the world, public health officials, policymakers and governments are collecting evidence-based information to establish the public health policies. Unfortunately, continued international travel, violations of lockdowns and social distancing, the lack of mask use, the emergence of mutant strains of the virus and lower adherence by a sector of the global population that remains sceptical of the protection offered by vaccines, or about any risks associated with vaccines, hamper these efforts. Here we examine the literature on the efficacy, effectiveness and safety of COVID-19 vaccines, with an emphasis on select categories of individuals and against new SARS-CoV-2 strains. The literature shows that these eight vaccines are highly effective in protecting the population from severe disease and death, but there are some issues concerning safety and adverse effects. Further, booster shots and variant-specific vaccines would also be required.
目前,世界卫生组织已授权使用 8 种针对 SARS-CoV-2 的疫苗,这些疫苗在 COVID-19 大流行期间可为世界人口提供一定程度的保护。虽然世界各地都在发表研究成果,但公共卫生官员、政策制定者和政府正在收集基于证据的信息,以制定公共卫生政策。不幸的是,持续的国际旅行、违反封锁和社交距离措施、缺乏口罩使用、病毒变异株的出现以及全球部分对疫苗提供的保护或与疫苗相关的任何风险持怀疑态度的人群的较低疫苗接种率,都妨碍了这些努力。在这里,我们研究了 COVID-19 疫苗的疗效、有效性和安全性的文献,重点关注特定类别的人群和针对新的 SARS-CoV-2 菌株。文献表明,这 8 种疫苗在保护人群免受严重疾病和死亡方面非常有效,但在安全性和不良反应方面存在一些问题。此外,还需要加强针和针对变异株的疫苗。